Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P5TR
|
|||
Former ID |
DIB005891
|
|||
Drug Name |
CGP-28014
|
|||
Synonyms |
Cgp 28014; 111757-17-6; Methanimidamide, N'-(1,6-dihydro-6-oxo-2-pyridinyl)-N,N-dipropyl-; N-(2-Oxopyridin-6-yl)-N',N'-di-n-propylformamidine; N'-(1,6-Dihydro-6-oxo-2-pyridinyl)-N,N-dipropylmethanimidamide; CGP-28014; N-(2-pyridone-6-yl)-N',N'-di-n-propylformamidine; cgp28014; CHEBI:79969; LS-90457
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Major depressive disorder [ICD-11: 6A70.3; ICD-10: F32.2] | Phase 2 | [1] | |
Company |
Novartis AG
|
|||
Structure |
Download2D MOL |
|||
Formula |
C12H19N3O
|
|||
Canonical SMILES |
CCCN(CCC)C=NC1=CC=CC(=O)N1
|
|||
InChI |
1S/C12H19N3O/c1-3-8-15(9-4-2)10-13-11-6-5-7-12(16)14-11/h5-7,10H,3-4,8-9H2,1-2H3,(H,14,16)
|
|||
InChIKey |
MEYPAYJYAZKERR-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 111757-17-6
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Catechol-O-methyl-transferase (COMT) | Target Info | Modulator | [1] |
BioCyc | L-dopa degradation | |||
Dopamine degradation | ||||
Noradrenaline and adrenaline degradation | ||||
KEGG Pathway | Steroid hormone biosynthesis | |||
Tyrosine metabolism | ||||
Metabolic pathways | ||||
Dopaminergic synapse | ||||
Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
Dopamine receptor mediated signaling pathway | ||||
Pathwhiz Pathway | Tyrosine Metabolism | |||
WikiPathways | Methylation Pathways | |||
Metapathway biotransformation | ||||
Estrogen metabolism | ||||
Biogenic Amine Synthesis | ||||
Dopamine metabolism | ||||
Phase II conjugation | ||||
Neurotransmitter Clearance In The Synaptic Cleft |
References | Top | |||
---|---|---|---|---|
REF 1 | CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure. Naunyn Schmiedebergs Arch Pharmacol. 1990 Sep;342(3):305-11. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.